https://www.news-medical.net/news/20231129/Clinical-trial-reveals-dapagliflozins-impact-on-heart-failure-and-type-2-diabetes-management.aspx
Researchers conducted a clinical trial on the effects of dapagliflozin on the urinary albumin-to-creatinine ratio (UACR) in patients with heart failure (HF) and type 2 diabetes mellitus (T2D).
Create an account or login to join the discussion